Global Surgical Robots Market (2022 to 2026) – Analysis By Component,

On Feb 21, 2022

[ad_1]

DUBLIN, February 21, 2022–(BUSINESS WIRE)–The “Global Surgical Robots Market” report has been added to ResearchAndMarkets.com’s offering.

The global surgical robots market was valued at $8052.67 Million in the year 2020 with North America region leading the regional market share.

Companies Mentioned

Intuitive Surgical
Stryker Corporation
Medtronic
Smith & Nephew
Zimmer Biomet
Accuray Incorporated
Renishaw
Asensus Surgical
Medrobotics Corporation
Think Surgical

The market is projected to display momentous growth with a very high CAGR during 2021-2026. The rising need for automation in healthcare, the growing geriatric population, and the rising prevalence of chronic diseases among the global population are some of the key factors driving the surgical robots market growth globally. In addition, increasing adoption and acceptance of robotic-assisted minimally invasive surgeries (MIS) fueling the demand for surgical robots as they offer better screening, greater precision, reduced pain and discomfort, shorter hospital stays and lower infection risk.

Furthermore, technological advancements and expanding medical applications of the surgical robots such as robotic assisted neuro-surgery, cardiac-surgery and other surgeries are expected to boost market growth in forthcoming years.

The COVID-19 pandemic had a substantial impact on the global market including the essential sector like healthcare. Following the World Health Organization’s (WHO) declaration of Covid-19 as a pandemic in March 2020, various federal and state governments imposed a variety of restrictions in an effort to contain the virus, including social distancing, travel restrictions, border closures, restrictions on public gatherings, work from home, supply chain logistical changes, and the closure of non-essential businesses. In addition, the Centers for Medicare & Medicaid Services (CMS) declared that all non-essential dental, surgical, and medical procedures and all elective surgeries, be postponed during the COVID-19 outbreak. This has massively impacted the business revenues of healthcare providers, and medical product suppliers.

Globally, the demand for robotic-assisted minimally invasive surgeries (MIS) is on the rise mainly due to the advantages associated with these procedures, such as smaller incisions, fewer cuts, decreased scarring, reduced pain, increased safety, faster recovery periods, and considerable cost savings. Robotic minimally invasive surgery adds to these advantages by ensuring greater accuracy, repeatability, control, and efficiency. In addition, surgical robots help surgeons overcome human limitations and eliminate impediments in conventional surgical tools and techniques, reducing burden on surgeons and delivering better clinical outcomes for patients.

In recent years, major market players have made strategic M&A to strengthen their market position, Stryker, for example, bought OrthoSensor and its Verasense intraoperative sensor technology in January 2021 to…